(NASDAQ: WVE) Wave Life Sciences's forecast annual revenue growth rate of 6.59% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 101.28%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.61%.
Wave Life Sciences's revenue in 2025 is $109,230,000.On average, 17 Wall Street analysts forecast WVE's revenue for 2025 to be $7,058,582,102, with the lowest WVE revenue forecast at $5,421,370,892, and the highest WVE revenue forecast at $12,726,713,307. On average, 17 Wall Street analysts forecast WVE's revenue for 2026 to be $9,253,177,381, with the lowest WVE revenue forecast at $0, and the highest WVE revenue forecast at $17,729,628,193.
In 2027, WVE is forecast to generate $24,528,911,348 in revenue, with the lowest revenue forecast at $5,406,658,895 and the highest revenue forecast at $67,232,154,436.